tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mike Matson, 646 are a BUY (85.79%), 102 are a HOLD (13.55%), 5 are a SELL (0.66%).
Analyst Mike Matson, currently employed at NEEDHAM, carries an average stock price target met ratio of 59.95% that have a potential upside of 26.88% achieved within 263 days.
Mike Matson’s has documented 1,297 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on MDT, Medtronic PLC at 19-Feb-2025.
Analyst best performing recommendations are on PSNL (PERSONALIS).
The best stock recommendation documented was for PSNL (PERSONALIS) at 6/21/2024. The price target of $3.5 was fulfilled within 28 days with a profit of $2.28 (186.89%) receiving and performance score of 66.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$51
$12.61 (32.85%)
$40
1 months ago
(22-Jan-2025)
13/28 (46.43%)
$11.5 (29.11%)
184
Buy
$61
$22.61 (58.90%)
$53
2 months 13 days ago
(09-Dec-2024)
2/15 (13.33%)
$27.06 (79.73%)
36
Buy
$36
$-2.39 (-6.23%)
$32
3 months 23 days ago
(30-Oct-2024)
10/10 (100%)
$1.17 (3.36%)
113
Buy
$40
$1.61 (4.19%)
$35
3 months 23 days ago
(30-Oct-2024)
5/12 (41.67%)
$5.17 (14.84%)
302
Buy
$40
$1.61 (4.19%)
$30
3 months 23 days ago
(30-Oct-2024)
6/10 (60%)
$5.17 (14.84%)
121
Which stock is Mike Matson is most bullish on?
Which stock is Mike Matson is most reserved on?
What Year was the first public recommendation made by Mike Matson?
